Clinical Effectiveness of Ashwagandha in Menopause: A Systematic Review
DOI:
https://doi.org/10.71341/bmwj.v3i2.61Keywords:
ashwagandha, withania somnifera, menopause, quality of lifeAbstract
Background: Menopause is the natural and permanent cessation of menses, often accompanied by vasomotor symptoms that can impact a person's quality of life. Ashwagandha (Withania somnifera), also known as Indian ginseng, has been shown to ameliorate some of the symptoms associated with menopause in women, particularly climacteric symptoms.
Objective: This study aimed to evaluate Ashwagandha (Withania somnifera) in reducing menopausal symptoms and improving quality of life, as measured by the Menopause Rating Scale (MRS) and the Menopause-Specific Quality of Life (MENQOL) questionnaire.
Methods: A systematic review was conducted following the PRISMA guidelines, with pre-defined keywords and pre-determined inclusion and exclusion criteria. Risk of bias was assessed using RoB 2 for RCTs and ROBINS-I for non-RCTs.
Results: Based on the inclusion criteria, 7 studies were identified: 4 randomized controlled trials (RCTs) and 3 non-randomized trials. The RCTs were judged to have low risk of bias, while the non-randomized trials were judged to have high (serious) risk of bias. Menopausal symptom outcomes were measured using MRS (2 studies), MENQOL (2 studies), both MRS and MENQOL (2 studies), and MENQOL with SGA (1 study). Six of the 7 studies showed significant improvement in menopausal symptoms and quality of life with the use of Ashwagandha (Withania somnifera), while the remaining study observed a tendency toward improvement but lacked a control group.
Conclusion: Ashwagandha (Withania somnifera) shows potential in alleviating menopausal symptoms and improving quality of life. These findings suggest that Ashwagandha may serve as a promising non-hormonal option to support integrative healthcare for women during the menopausal stage.
References
Burger, H. G., Dudley, E. C., Robertson, D. M., & Dennerstein, L. (2002). Hormonal changes in the menopause transition. Recent Progress in Hormone Research, 57, 257–275. https://doi.org/10.1210/rp.57.1.257
Choudhury, R., Coelho, K., Suryawanshi, S., Hajare, A., & Kumar, A. (2025). Effectiveness of multisymptom support for better relief and alleviation of common effects in perimenopause (EMBRACE PERIMENOPAUSE). Cureus, 17(6), e86091. https://doi.org/10.7759/cureus.86091
Davis, S. R., Pinkerton, J. V., Santoro, N., & Simoncini, T. (2023). Menopause—Biology, consequences, supportive care, and therapeutic options. Cell, 186(19), 4038–4058. https://doi.org/10.1016/j.cell.2023.08.013
Ding, T., Yan, W., Zhou, T., Shen, W., Wang, T., Li, M., Zhou, S., Wu, M., Dai, J., Huang, K., Zhang, J., Chang, J., & Wang, S. (2022). Endocrine disrupting chemicals impact on ovarian aging: Evidence from epidemiological and experimental studies. Environmental Pollution, 305, 119269. https://doi.org/10.1016/j.envpol.2022.119269
Dixit, N., Ikramuddin, M., & Dubey, A. (2023). Effect of Menoveda Akira Tablet against anxiety; an in-vivo zebra fish model study. International Journal of Pharmacy and Pharmaceutical Research, 27(1), 482-492. https://doi.org/10.25166/IJPPR.2023.27.1.37
Fang, Y., Liu, F., Zhang, X., Chen, L., Liu, Y., Yang, L., Zheng, X., Liu, J., Li, K., & Li, Z. (2024). Mapping global prevalence of menopausal symptoms among middle-aged women: A systematic review and meta-analysis. BMC Public Health, 24, Article 1767. https://doi.org/10.1186/s12889-024-19280-5
Gartoulla, P., Worsley, R., Bell, R. J., & Davis, S. R. (2015). Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause, 22(7), 694–701. https://doi.org/10.1097/GME.0000000000000383
Gopal, S., Ajgaonkar, A., Kanchi, P., Kadam, A., Thakur, V., Chauhan, S., & Langade, D. (2021). Effect of an ashwagandha (Withania somnifera) root extract on climacteric symptoms in women during perimenopause: A randomized, double-blind, placebo-controlled study. Journal of Obstetrics and Gynaecology Research, 47(12), 4414–4423. (Catatan: Ini adalah studi KSM-66 yang dirujuk oleh Isukapalli Vani). https://doi.org/10.1111/jog.15030
Inman, Z., & Flaws, J. A. (2024). Endocrine disrupting chemicals, reproductive aging, and menopause: A review. Reproduction, 168(5), e240113. https://doi.org/10.1530/REP-24-0113
Isukapalli, V., et al. (2022). Efficacy and safety of Ashwagandha root extract in menopausal women: A randomized, double-blind, placebo-controlled trial. Journal of Obstetrics and Gynaecology Research, 48(9), 2150–2161.
Khan, S. J., Kapoor, E., Faubion, S. S., & Kling, J. M. (2023). Vasomotor symptoms during menopause: A practical guide on current treatments and future perspectives. International Journal of Women’s Health, 15, 273–287. https://doi.org/10.2147/IJWH.S365808
Koothirezhi, R., & Ranganathan, S. (2023). Postmenopausal syndrome. In StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK560787/
Modi, M. B., Donga, S. B., & Dei, L. (2012). Clinical evaluation of Ashokarishta, Ashwagandha Churna and Praval Pishti in the management of menopausal syndrome. Ayu, 33(4), 511–516. https://doi.org/10.4103/0974-8520.110529
Nappi, R. E., Kroll, R., Siddiqui, E., Stoykova, B., Rea, C., Gemmen, E., & Schultz, N. M. (2021). Global cross-sectional survey of women with vasomotor symptoms associated with menopause: Prevalence and quality of life burden. Menopause, 28(8), 875–882. https://doi.org/10.1097/GME.0000000000001793
Phipps, A. I., Ichikawa, L., Bowles, E. J., Carney, P. A., Kerlikowske, K., Miglioretti, D. L., & Buist, D. S. (2010). Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates. Maturitas, 67(1), 60–66. https://doi.org/10.1016/j.maturitas.2010.04.015
Pingali, U., Nutalapati, C., & Wang, Y. (2025). Ashwagandha and shatavari extracts dose-dependently reduce menopause symptoms, vascular dysfunction, and bone resorption in postmenopausal women: A randomized, double-blind, placebo-controlled study. Journal of Menopausal Medicine, 31(1), 21–34. https://doi.org/10.6118/jmm.24025
Santoro, N. (2016). Perimenopause: From research to practice. Journal of Women’s Health, 25(4), 332–339. https://doi.org/10.1089/jwh.2015.5556
Steels, E., Steels, M., Harold, M., Adams, L., & Coulson, S. (2018). A double-blind, randomized, placebo-controlled trial evaluating safety and efficacy of an ayurvedic botanical formulation in reducing menopausal symptoms in otherwise healthy women. Journal of Herbal Medicine, 11, 30–35. https://doi.org/10.1016/j.hermed.2018.01.001
Tomar, R., Sharma, S., Kumari, I., Gangurde, V., Ota, S., Dua, P., Khanduri, S., Yadav, B., Rana, R., Singhal, R., Srikanth, N., Padhi, M. M., & Dhiman, K. S. (2017). Clinical efficacy and safety of Ashokarishta, Ashvagandha churna and Pravala pishti in the management of menopausal syndrome: A prospective open-label multicenter study. Journal of Research in Ayurvedic Sciences, 1(1), 9–16. https://doi.org/10.5005/jp-journals-10064-0002
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Frederick Wirawan, Putu Enrico Pramana Okaniawan, Isharyah Sunarno
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
License
This work is licensed under the Creative Commons Attribution-ShareAlike 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercial purposes.
- Adaptation — mixing, changing, and developing materials for any purpose, even commercial ones.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
